The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The COVID-19 pandemic may have ended a long time ago, but the European Commission is still ordering 146 million doses of coronavirus vaccines, Berliner Zeitung reports. The costs, however, remain ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

After Moderna proved in 2021 that messenger RNA vaccines could blunt the impact of a pandemic, it seemed the playbook for future outbreaks was set: A few months of vaccine trials, and then an ...

COVID-19 vaccines were not associated with increased risk for thyroid diseases but were associated with increased risk for exacerbated hypothyroidism.

The Moderna and Pfizer agreements include options for a total of 600 million doses, 300 million apiece, but these can only be exercised with additional funding from Congress, according to HHS.

Moderna is not the only company to reach an agreement with BARDA for bird flu vaccines. BARDA also has a deal in place for 150 million doses of CSL Seqirus’ protein-based H5N1 bird flu vaccine.